Thymosin-β4 Analog TB-500 (10mg)

• TB-500 (Thymosin-β4 analog) is a synthetic peptide modeled after the naturally occurring 43-amino-acid Thymosin-β4 protein.
• Investigated in pre-clinical research for its role in actin regulation, cell migration, and angiogenesis.
• Each batch independently verified for purity and identity through Vanguard Laboratory.

Thymosin-β4 (TB-500 analog) has been studied for its involvement in actin polymerization and cellular motility, factors linked to wound healing and angiogenic signaling.

Experimental studies demonstrate that Thymosin-β4 can enhance endothelial migration and capillary formation through integrin-linked kinase pathways 

Reviews in endocrinology and cardiology literature highlight potential applications in cardiac and epithelial regeneration 

Regulatory Status: TB-500 is not FDA-approved for human or veterinary use and is provided strictly for laboratory research applications.